1. Home >
  2. Investors >
  3. Sovereign Wealth Fund >
  4. Polski Fundusz Rozwoju >
  5. M&A

Polski Fundusz Rozwoju Mergers & Acquisitions

Polski Fundusz Rozwoju M&A Summary

Sign-up to view Polski Fundusz Rozwoju’s full profile and discover more middle-market sovereign wealth fund investors just like it.

M&A Summary

  • M&A Total Activity2
    • M&A Buy Activity2
  • M&A Buy/Sell Connections1

Polski Fundusz Rozwoju

Polski Fundusz Rozwoju S.A.

Krucza Street 50,
Warsaw, 00-025
Poland
+48 22 274 23 72
www.pfr.pl
info@pfr.pl

All (2) Buy (2) Sell (0)
Date Target Value
$mlns 		Transaction Type Acquirer Seller SRC
Link
2021-09-10 Proteon Pharmaceuticals · Life Science
Lodz, Poland · www.proteonpharma.com

Proteon Pharmaceuticals is a biotechnology company develops an advanced technology platform that uses molecular biology, genomics, bioinformatics and artificial intelligence (AI) to create precise and safe antibacterial solutions based on bacteriophages. Proteon Pharmaceuticals is based in Lodz, Poland.

- Growth Capital

Polski Fundusz Rozwoju PE

-

Try Mergr Free — See This and 220,453+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Try Free

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 82K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.

Mergr

Solution for

Product

Company

Legal